Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-102 for Subcutaneous Abdominal Adiposity
NCT01096979Phase 2Completed
- Sponsor
- Neothetics
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LIPO-102 in subcutaneous abdominal adiposity, sponsored by Neothetics. Started Oct 2009; status: completed.
02
Drugs
LIPO-102
03
Conditions
subcutaneous abdominal adiposity
Beyond the preview
Go deeper on NCT01096979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096979.